Pancreatic Cancer is an aggressive and quickly spreading disease where few symptoms exist until the cancer is very advanced, and because of this, pancreatic cancer has a poor prognosis even with early detection. It occurs when malignant cells form in the tissues of the pancreas, typically in the exocrine cells (the cells that produce digestive juices). Pancreatic cancer typically affects individuals who are African American, who are overweight, have diabetes, smoke, have pancreatitis, or have a family history of pancreatic cancer. Treatments for pancreatic cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and clinical trials. If the pancreatic cancer has not spread to distant organs but cannot be completely removed by surgery, it is called locally advanced (may occur because it is too close to nearby blood vessels, making removal difficult). When the cancer cannot be removed entirely by surgery, it is known as unresectable, and surgery would only be performed to relieve symptoms if possible. This distinction is made based on the idea that the mortality/morbidity of resection is not substantially less than the improvement in quantity and quality of life.
Unresectable Pancreatic Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Unresectable Pancreatic Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 2008 products for the study of Unresectable Pancreatic Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.